Disappoints on Debt Repayment

25 MAY 2016 Quarterly Update COX & KINGS BUY MIDCAPS Target Price: Rs 286

Disappoints on debt repayment Cox & Kings’s (C&K) FY16 revenue at Rs 24 bn (up 6% YoY) and CMP : Rs 150 EBITDA at Rs 8.2 bn (up 1% YoY) were broadly in line with our Potential Upside : 91% expectations. PAT at Rs 539 mn (our est. Rs 2.8 bn) was affected due to goodwill write-off as a result of sale of subsidiary. However, what disappointed us was debt repayment guidance of Rs 3-5 bn not panning MARKET DATA out (due to higher capex/working capital). FY16 net debt came down to No. of Shares : 169mn Free Float : 51% Rs 22.5 bn primarily due to cash from sale of subsidiary. Market Cap : Rs25bn Management does not see deterioration in working capital but expects 52-week High / Low : Rs317 / Rs141 capex to be higher at Rs 3 bn in FY17 led by PGL expansion Avg. Daily vol. (6mth) : 497,006 shares (Rs 1.1bn); India capex at Rs 0.8 bn (largely on account of SAP Bloomberg Code : COXK IB Equity implementation); and Rs 0.7 bn towards Meininger expansion. Promoters Holding : 49% FII / DII : 34% / 3% Management guided cash of Rs 4 bn from sale of subsidiaries coupled with operating cash flow will be used to reduce debt.

Q4 highlights: In a seasonally weak quarter (Q4 contributes ~10% of yearly EBITDA),C&K reported 4% decline in revenue to Rs 4.7 bn. Despite higher ad spends in domestic leisure and impact of terror attack, EBITDA (adj. for forex gain) increased 21% YoY to Rs 0.6 bn due to cost controls and lower maintenance expense in the Education segment. Q4 PAT was affected due to restructuring of the international leisure businesses. While C&K realized a gain of Rs 2.2 bn from sale of its subsidiaries, it also wrote off goodwill amounting to ~Rs 7.5 bn. This resulted in Q4 reporting a net loss of Rs 3.1 bn.

Estimates and valuation:While we expect overall business growth to continue, higher depreciation and interest outgo reduce our FY17 and FY18 EPS estimate to Rs 16 and Rs 20 (Rs 24 and Rs 28 earlier). Maintain BUY with revised TP of Rs286(14x FY18E EPS) vs. 336 earlier.Key triggers for the stock (factored in) would be: (1) strong FCF generation; (2) meaningful debt reduction; and (3) no exceptional items by way of M&A.

Financial summary (Consolidated) Key drivers Y/E March FY15 FY16 FY17E FY18E Revenue growth FY16 FY17E FY18E Sales (Rs mn) 25,691 23,519 22,223 24,757 India business 13% 16% 15%

Adj PAT (Rs mn) 4,004 3,945 2,864 3,605 Meininger 2% 7% 20%

Con. EPS* (Rs) - - 22.3 26.6 Education 4% 8% 8%

EPS (Rs) 23.7 23.3 16.2 20.4 Int. Leisure 4% -45% 5%

Change YOY (%) 55.0 (1.5) (30.4) 25.9 P/E (x) 6.3 6.4 9.2 7.3 Price performance RoE (%) 18.5 15.7 11.1 12.5 150 Sensex Cox And Kings RoCE (%) 11.2 10.3 10.3 11.7 100 EV/E (x) 4.8 5.5 5.2 4.4

DPS (Rs) 1.0 1.0 1.0 1.0 50

Source: *Consensus broker estimates, Company, Axis Capital 0 Apr-15 Jul-15 Oct-15 Jan-16 Apr-16

25 MAY 2016 Quarterly Update COX & KINGS MIDCAPS

Segmental highlights

India business (23% of FY16 revenue) Q4 witnessed tepid inbound tourist growth, resulting in 6% YoY growth in revenue to Rs 1.1 bn. Higher advertising and marketing expenditure due to intense competition resulted in EBITDA declining 8% YoY to Rs 350 mn. The division has seen robust demand during the summer months. With 30% market share in Indian travel and tourism, we believe C&K will be a key beneficiary of secular growth in the industry. We expect India business to sustain 15% revenue CAGR over FY16-18 with EBIDTA margin of ~50%.

Exhibit 1: India business - financials Revenue EBITDA EBITDA margin (RHS) 8 70% (Rs bn) 7 60% 7.2 6 6.3 50% 5 5.4 40% 4 4.8 4.2 30% 3 3.6 3.1 2 20% 2.4 2.6 2.1 1 10% 0 0% FY14 FY15 FY16 FY17E FY18E

Source: Company Axis Capital

International business Education business (28% of FY16 revenue): Revenue increased 5% YoY to Rs 1 bn in Q4. Tight cost control and even spread of maintenance expenses over Q3 and Q4 led to curtailed losses during a lean season. In Q4, the division reported EBITDA breakeven (loss of Rs 320 mn in Q4FY15). PGL has already booked 86% of revenue targets for FY17 and 42% for FY18. For FY17, PGL will have ~9,300 beds available. Average revenue per bed night in FY16 for PGL (UK) increased to GBP 67 (GBP 66).

Expansion of PGL Australia has seen encouraging results, where 533 beds would be available for FY17. PGL plans to add 1,500 beds over the next couple of years. PGL is expected to garner greater market share as local education authorities (PGL’s competitors) are facing budget cuts. We expect 8-10% revenue CAGR over FY16- 18and EBITDA margin of 41%.

25 MAY 2016 Quarterly Update COX & KINGS MIDCAPS

Exhibit 2: Education business - financials Revenue EBITDA EBITDA margin (RHS) 10 70% (Rs bn) (%) 60% 8 7.8 50% 6 7.2 6.4 6.7 40% 5.4 4 30% 20% 3.0 3.3 2 2.6 2.9 2.3 10% 0 0% FY14 FY15 FY16 FY17E FY18E

Source: Company Axis Capital

Meininger – offering affordable stay for young travellers (15% of FY16 revenue):Paris and Brussels attack affected bed capacity utilization as well as rates across Europe. Meininger Brussels (727 beds), in particular, was severely affected in the aftermath of Brussels airport closure. Revenue for Q4 declined 11% YoY to Rs 730 mn, while EBITDA declined to Rs 70 mn (Rs 100 mn in Q4FY15).

For FY16, Meininger had 7,025 beds (6,949 beds in FY15) with an occupancy level of ~77% (75% in FY15). Average revenue per bed night increased ~4% to EUR 28.4. It is seeing strong booking trends for the coming months, which should help in yield management. The division expects to add beds at key European destinations like Paris, Madrid, Edinburg, Florence, Oslo to expand its service offerings. We expect 12% revenue CAGR over FY16-18 with EBITDA margin at 34%.

Exhibit 3: Meininger - financials Revenue EBITDA EBITDA margin (RHS) 5 70% (Rs bn) (%) 4.7 60% 4 3.9 50% 3.6 3.6 3 3.3 40%

2 30% 20% 1.7 1 1.2 1.3 1.4 10% 1.0 0 0% FY14 FY15 FY16 FY17E FY18E

Source: Company Axis Capital

Leisure business – offering customized international tours (29% of FY16 revenue):FY16 saw C&K rebalancing its international leisure portfolio wherein it disposed Explore Worldwide for GBP 25.8 mn (December’15). Further, in Q4, C&K concluded a 3 step deal: (1) Sale of 100% stake in Laterooms UK for GBP 20 mn (acquired in Oct’15); (2) C&K’s 66%-owned subsidiary Holidaybreak has sold 100% of its holding in Superbreak for net consideration of GBP 9.25 mn; and

25 MAY 2016 Quarterly Update COX & KINGS MIDCAPS

(3) C&K has acquired 49% stake of Malvern for GBP 6.37 mn (remaining 51% being owned by a private equity investor). Malvern’s only investments are Laterooms and Superbreaks, which were sold by C&K. The company will receive net consideration of GBP 22.8 mn for its 51% stake in Laterooms and 17% stake in Superbreak. With this transaction, C&Khas recovered its investment in Laterooms (19 mn GBP), while retaining 49% stake in these entities. This rebalancing will improve the margin profile of C&K from FY17.

In Q4, revenue from continuing operations increased 29% to Rs 1 bn, while EBITDA stood at Rs 55 mn (Rs 290 mn in Q4FY15) on the back of strong performance in Dubai (now accounts for 35% of the division’s EBITDA). C&K is a niche tour operator in Australia, Dubai, UK, USA and Japan. We expect the division to report 5% revenue CAGR over FY16-18 (inline with growth in world travel industry). However, we expect EBITDA margin to improve to 45% in FY17 and FY18, as low margin Laterooms is hived off.

Exhibit 4: International leisure - financials Revenue EBITDA EBITDA margin (RHS) 8 70% (Rs bn) (%) 60% 6 6.5 6.7 50% 6.1 40% 4 30% 3.7 3.9 2 20% 2.2 2.4 1.9 1.7 1.7 10% 0 0% FY14 FY15 FY16 FY17E FY18E

Source: Company Axis Capital

25 MAY 2016 Quarterly Update COX & KINGS MIDCAPS

Exhibit 5: Results update Quarter ended 12 months ended

(Rs. mn) Mar-16 Mar-15 % Chg Dec-15 % Chg FY17E FY16 % Chg Net Sales 4,710 4,896 (3.8) 5,119 (8.0) 22,223 23,519 (5.5) EBIDTA 740 1,702 (56.5) 1,159 (36.1) 8,690 8,669 0.2 Other income 118 125 (5.9) 91 29.1 300 301 (0.4) PBIDT 858 1,827 (53.1) 1,250 (31.4) 8,990 8,970 0.2 Depreciation 532 270 96.9 393 35.2 1,369 1,485 (7.9) Interest 636 589 8.1 625 1.8 2,536 2,537 (0.0) PBT (311) 969 (132.1) 231 (234.2) 5,086 4,948 2.8 Tax (161) 501 (132.2) 238 (167.9) 1,322 1,590 (16.8) Profit from associates 0 (9) (102.9) (2) (116.4) (900) 595 (251.1) Minority Interest (1,985) (188) - 11 - 0 (9) - Adjusted PAT 1,836 646 184.3 (563) (425.9) 2,864 3,945 (27.4) Extra ordinary income/ (exp.) (4,891) 0 - 1,631 (399.9) 0 0 - Reported PAT (3,055) 646 (573.1) 1,067 (386.3) 2,864 3,945 (27.4) No. of shares (mn) 169 169 - 169 - 177 169 - EBIDTA margin (%) 15.7 34.8 - 22.6 - 39.1 36.9 - PBIDT margin (%) 18.2 37.3 - 24.4 - 40.5 38.1 - EPS - annualized (Rs) 43.4 15.3 184.3 (13.3) (425.9) 16.2 23.3 (30.4)

Source: Company, Axis Capital

25 MAY 2016 Quarterly Update COX & KINGS MIDCAPS Financial summary (Consolidated)

Profit &loss (Rsmn) Cash flow (Rsmn) Y/E March FY15 FY16 FY17E FY18E Y/E March FY15 FY16 FY17E FY18E

Net sales 25,691 23,519 22,223 24,757 Profit before tax 5,423 4,948 5,086 6,317 Other operating income - - - - Depreciation & Amortisation (1,983) (1,485) (1,369) (1,457) Total operating income 25,691 23,519 22,223 24,757 Chg in working capital (3,874) (2,368) 301 (1,977) Cost of goods sold - - - - Cash flow from operations 1,623 5,013 7,968 6,483 Gross profit 25,691 23,519 22,223 24,757 Capital expenditure (1,813) 3,770 (2,541) (2,500) Gross margin (%) 100.0 100.0 100.0 100.0 Cash flow from investing 12,466 3,474 (2,241) (2,200) Total operating expenses (15,576) (14,850) (13,533) (14,954) Equity raised/ (repaid) 10,293 - 36 - EBITDA 10,115 8,669 8,690 9,803 Debt raised/ (repaid) (18,031) 2,980 (4,000) (4,000) EBITDA margin (%) 39.4 36.9 39.1 39.6 Dividend paid (160) (169) (177) (177) Depreciation (1,983) (1,485) (1,369) (1,457) Cash flow from financing (13,819) (4,101) (6,976) (6,805) EBIT 8,132 7,184 7,322 8,346 Net chg in cash 271 4,385 (1,249) (2,522) Net interest (3,243) (2,537) (2,536) (2,329) Other income 535 301 300 300 Key ratios Profit before tax 5,423 4,948 5,086 6,317 Y/E March FY15 FY16 FY17E FY18E Total taxation (1,433) (1,590) (1,322) (1,643) OPERATIONAL Tax rate (%) 26.4 32.1 26.0 26.0 FDEPS (Rs) 23.7 23.3 16.2 20.4 Profit after tax 3,991 3,359 3,764 4,675 CEPS (Rs) 17.1 12.0 24.0 28.7 Minorities 31 595 (900) (1,070) DPS (Rs) 1.0 1.0 1.0 1.0 Profit/ Loss associate co(s) (17) (9) - - Dividend payout ratio (%) 18.4 31.4 6.2 4.9 Adjusted net profit 4,004 3,945 2,864 3,605 GROWTH Adj. PAT margin (%) 15.6 16.8 12.9 14.6 Net sales (%) 11.3 (8.5) (5.5) 11.4 Net non-recurring items (3,087) (3,406) - - EBITDA (%) 13.6 (14.3) 0.2 12.8 Reported net profit 918 539 2,864 3,605 Adj net profit (%) 92.2 (1.5) (27.4) 25.9 FDEPS (%) 55.0 (1.5) (30.4) 25.9 Balance sheet (Rsmn) PERFORMANCE Y/E March FY15 FY16 FY17E FY18E RoE (%) 18.5 15.7 11.1 12.5 Paid-up capital 847 847 883 883 RoCE (%) 11.2 10.3 10.3 11.7 Reserves & surplus 25,101 23,517 26,204 29,632 EFFICIENCY Net worth 33,572 30,839 34,462 38,961 Asset turnover (x) 0.4 0.4 0.4 0.4 Borrowing 38,030 41,010 37,010 33,010 Sales/ total assets (x) 0.3 0.3 0.2 0.3 Other non-current liabilities 255 2,102 2,102 2,102 Working capital/ sales (x) 0.1 0.2 0.3 0.3 Total liabilities 89,899 93,623 91,660 92,946 Receivable days 167.7 217.1 214.7 214.7 Gross fixed assets 63,322 59,552 62,093 64,593 Inventory days 5.5 7.2 6.0 5.6 Less: Depreciation (10,381) (11,866) (13,234) (14,691) Payable days 399.7 459.3 461.1 431.6 Net fixed assets 52,942 47,686 48,859 49,902 FINANCIAL STABILITY Add: Capital WIP - - - - Total debt/ equity (x) 1.3 1.3 1.1 0.9 Total fixed assets 52,942 47,686 48,859 49,902 Net debt/ equity (x) 0.8 0.7 0.6 0.5 Total Investment 604 1,202 1,202 1,202 Current ratio (x) 2.0 2.3 2.3 2.2 Inventory 236 292 223 229 Interest cover (x) 2.5 2.8 2.9 3.6 Debtors 11,805 13,986 13,072 14,563 VALUATION Cash & bank 14,057 18,442 17,193 14,671 PE (x) 6.3 6.4 9.2 7.3 Loans & advances 10,255 12,016 11,111 12,379 EV/ EBITDA (x) 4.8 5.5 5.2 4.4 Current liabilities 18,042 19,672 18,086 18,873 EV/ Net sales (x) 1.9 2.0 2.0 1.8 Net current assets 18,310 25,064 23,514 22,969 PB (x) 1.0 1.0 1.0 0.9 Other non-current assets - - - - Dividend yield (%) 0.7 0.7 0.7 0.7 Total assets 89,899 93,623 91,660 92,946 Free cash flow yield (%) - 0.3 0.2 0.2

Source: Company, Axis Capital Source: Company, Axis Capital

25 MAY 2016 Quarterly Update COX & KINGS MIDCAPS

Disclosures:

The following Disclosures are being made in compliance with the SEBI Research Analyst Regulations 2014 (herein after referred to as the Regulations).

1. Axis Securities Ltd. (ASL) is a SEBI Registered Research Analyst having registration no. INH000000297. ASL, the Research Entity (RE) as defined in the Regulations, is engaged in the business of providing Stock broking services, Depository participant services & distribution of various financial products. ASL is a subsidiary company of Axis Bank Ltd. Axis Bank Ltd. is a listed public company and one of India’s largest private sector bank and has its various subsidiaries engaged in businesses of Asset management, NBFC, Merchant Banking, Trusteeship, Venture Capital, Stock Broking, the details in respect of which are available on www.axisbank.com. 2. ASL is registered with the Securities & Exchange Board of India (SEBI) for its stock broking & Depository participant business activities and with the Association of Mutual Funds of India (AMFI) for distribution of financial products and also registered with IRDA as a corporate agent for insurance business activity. 3. ASL has no material adverse disciplinary history as on the date of publication of this report. 4. I/We, authors (Research team) and the name/s subscribed to this report, hereby certify that all of the views expressed in this research report accurately reflect my/our views about the subject issuer(s) or securities. I/We also certify that no part of my/our compensation was, is, or will be directly or indirectly related to the specific recommendation(s) or view(s) in this report. I/we or my/our relative or ASL does not have any financial interest in the subject company. Also I/we or my/our relative or ASL or its Associates may have beneficial ownership of 1% or more in the subject company at the end of the month immediately preceding the date of publication of the Research Report. Since associates of ASL are engaged in various financial service businesses, they might have financial interests or beneficial ownership in various companies including the subject company/companies mentioned in this report. I/we or my/our relative or ASL or its associate does not have any material conflict of interest. I/we have not served as director / officer, etc. in the subject company in the last 12-month period.

Research Team

Sr. No Name Designation E-mail 1 Sunil Shah Head of Research [email protected] 2 Pankaj Bobade Research Analyst [email protected] 3 Priyakant Dave Research Analyst [email protected] 4 Akhand Singh Research Analyst [email protected] 5 Bunty Chawla Research Analyst [email protected] 6 Hiren Trivedi Research Associate [email protected] 7 Poonam Darade Research Associate [email protected] 8 Sankar Narayanan Database Manager [email protected] 9 Kiran Gawle Associate [email protected] 5. ASL has not received any compensation from the subject company in the past twelve months. ASL has not been engaged in market making activity for the subject company.

6. In the last 12-month period ending on the last day of the month immediately preceding the date of publication of this research report, ASL or any of its associates may have:

i. Received compensation for investment banking, merchant banking or stock broking services or for any other services from the subject company of this research report and / or; ii. Managed or co-managed public offering of the securities from the subject company of this research report and / or; iii. Received compensation for products or services other than investment banking, merchant banking or stock broking services from the subject company of this research report; ASL or any of its associates have not received compensation or other benefits from the subject company of this research report or any other third-party in connection with this report

Term& Conditions: This report has been prepared by ASL and is meant for sole use by the recipient and not for circulation. The report and information contained herein is strictly confidential and may not be altered in any way, transmitted to, copied or distributed, in part or in whole, to any other person or to the media or reproduced in any form, without prior written consent of ASL. The report is based on the facts, figures and information that are considered true, correct, reliable and accurate. The intent of this report is not recommendatory in nature. The information is obtained from publicly available media or other sources believed to be reliable. Such information has not been independently verified and no guaranty, representation of warranty, express or implied, is made as to its accuracy, completeness or correctness. All such information and opinions are subject to change without notice. The report is prepared solely for informational purpose and does not constitute an offer document or solicitation of offer to buy or sell or subscribe for securities or other financial instruments for the clients. Though disseminated to all the customers simultaneously, not all customers may receive this report at the same time. ASL will not treat recipients as customers by virtue of their receiving this report.

25 MAY 2016 Quarterly Update COX & KINGS MIDCAPS

Disclaimer :

Nothing in this report constitutes investment, legal, accounting and tax advice or a representation that any investment or strategy is suitable or appropriate to the recipient’s specific circumstances. The securities and strategies discussed and opinions expressed, if any, in this report may not be suitable for all investors, who must make their own investment decisions, based on their own investment objectives, financial positions and needs of specific recipient.

This report may not be taken in substitution for the exercise of independent judgment by any recipient. Each recipient of this report should make such investigations as it deems necessary to arrive at an independent evaluation of an investment in the securities of companies referred to in this report (including the merits and risks involved), and should consult its own advisors to determine the merits and risks of such an investment. Certain transactions, including those involving futures, options and other derivatives as well as non-investment grade securities involve substantial risk and are not suitable for all investors. ASL, its directors, analysts or employees do not take any responsibility, financial or otherwise, of the losses or the damages sustained due to the investments made or any action taken on basis of this report, including but not restricted to, fluctuation in the prices of shares and bonds, changes in the currency rates, diminution in the NAVs, reduction in the dividend or income, etc. Past performance is not necessarily a guide to future performance. Investors are advise necessarily a guide to future performance. Investors are advised to see Risk Disclosure Document to understand the risks associated before investing in the securities markets. Actual results may differ materially from those set forth in projections. Forward-looking statements are not predictions and may be subject to change without notice.

ASL and its affiliated companies, their directors and employees may; (a) from time to time, have long or short position(s) in, and buy or sell the securities of the company(ies) mentioned herein or (b) be engaged in any other transaction involving such securities or earn brokerage or other compensation or act as a market maker in the financial instruments of the company(ies) discussed herein or act as an advisor or investment banker, lender/borrower to such company(ies) or may have any other potential conflict of interests with respect to any recommendation and other related information and opinions. Each of these entities functions as a separate, distinct and independent of each other. The recipient should take this into account before interpreting this document.

ASL and / or its affiliates do and seek to do business including investment banking with companies covered in its research reports. As a result, the recipients of this report should be aware that ASL may have a potential conflict of interest that may affect the objectivity of this report. Compensation of Research Analysts is not based on any specific merchant banking, investment banking or brokerage service transactions. ASL may have issued other reports that are inconsistent with and reach different conclusion from the information presented in this report.

Neither this report nor any copy of it may be taken or transmitted into the United State (to U.S. Persons), Canada, or Japan or distributed, directly or indirectly, in the United States or Canada or distributed or redistributed in Japan or to any resident thereof. If this report is inadvertently sent or has reached any individual in such country, especially, USA, the same may be ignored and brought to the attention of the sender. This report is not directed or intended for distribution to, or use by, any person or entity who is a citizen or resident of or located in any locality, state, country or other jurisdiction, where such distribution, publication, availability or use would be contrary to law, regulation or which would subject ASL to any registration or licensing requirement within such jurisdiction. The securities described herein may or may not be eligible for sale in all jurisdictions or to certain category of investors.

The Disclosures of Interest Statement incorporated in this document is provided solely to enhance the transparency and should not be treated as endorsement of the views expressed in the report. The Company reserves the right to make modifications and alternations to this document as may be required from time to time without any prior notice. The views expressed are those of the analyst(s) and the Company may or may not subscribe to all the views expressed therein.

Axis Securities Limited, Corporate office: Unit No. 2, Phoenix Market City, 15, LBS Road, Near Kamani Junction, Kurla (west), Mumbai-400070, Tel No. – 18002100808/022-61480808, Regd. off.- Axis House, 8th Floor, Wadia International Centre, Pandurang Budhkar Marg, Worli, Mumbai – 400 025. Compliance Officer: Anand Shaha, Email: [email protected], Tel No: 022-42671582.